Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/18780871

J. Natl. Cancer Inst. 2008 Sep 17 100 18 1331; author reply 1332-4

Download in:

View as

Triples

General Info

PMID
18780871